Insiders · Profile

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS at ANI PHARMACEUTICALS. Filing since 17 Mar 2022. CIK 0001870913

Company
Date
Role
Action
Shares
Amount
Of holding
21 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
52,988
$4.79M
10.9%
20 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
47,012
$4.24M
8.8%
15 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
52,990
$4.62M
9.1%
14 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
47,010
$4.21M
7.4%
9 May 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
700
$53.78K
0.1%
18 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
2,743
$170.07K
0.4%
17 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
14,257
$900.47K
2.2%
16 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
22,000
$1.41M
3.3%
15 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,000
$697.18K
1.6%
21 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
20,000
$1.18M
2.8%
20 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,447
$685.22K
1.6%
18 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,607
$644.48K
1.5%
17 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
7,946
$487.96K
1.1%
20 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
12,855
$794.57K
1.7%
17 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
5,836
$362.36K
0.8%
16 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
16,459
$1.05M
2.1%
15 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
14,850
$978.02K
1.9%
19 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
16,809
$1.10M
2.1%
18 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,423
$677.29K
1.3%
17 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
9,520
$622.61K
1.2%
16 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
5,834
$386.21K
0.7%
15 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
7,414
$491.77K
0.9%
8 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,000
$671.70K
1.2%
7 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
15,085
$1.00M
1.8%
6 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
14,822
$970.40K
1.7%
5 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,093
$659.58K
1.1%
23 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
15,000
$846.60K
1.7%
22 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
5,692
$318.47K
0.6%
19 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
4,524
$251.40K
0.5%
18 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
9,784
$541.06K
1.1%
17 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,000
$551.10K
1.1%
16 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
5,000
$278.15K
0.5%
19 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
25,000
$1.32M
2.6%
18 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
13,026
$683.08K
1.3%
15 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,974
$627.92K
1.2%
17 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
13,000
$663.00K
1.3%
16 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
6,448
$333.10K
0.6%
15 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
7,647
$410.19K
0.8%
14 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
22,095
$1.17M
2.1%
19 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,000
$570.60K
1.0%
18 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
6,242
$360.66K
0.6%
17 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
8,758
$512.61K
0.8%
16 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
13,063
$761.70K
1.2%
13 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,937
$687.33K
1.1%
19 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
25,333
$1.55M
2.3%
18 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
8,425
$519.32K
0.8%
15 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
16,242
$1.02M
1.4%
29 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
25,000
$1.58M
2.2%
28 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold at will
25,000
$1.58M
2.1%
15 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
22,110
$1.36M
1.8%
14 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
27,890
$1.71M
2.3%
21 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,500
$604.44K
0.9%
20 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
6,000
$309.12K
0.5%
19 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
5,969
$307.28K
0.5%
18 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
6,700
$347.33K
0.5%
17 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
9,831
$501.97K
0.8%
14 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
10,000
$504.30K
0.8%
22 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
13,500
$693.63K
64.6%
21 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,843
$615.24K
36.2%
20 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
14,657
$761.14K
30.9%
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Bought
5,000
$138.25K
37.1%
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Bought
5,000
$138.25K
opened
62 decisions on file.